DEVON, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate at various upcoming investor meetings and conferences. Armando Anido, Chairman and CEO, will present at the Jefferies London Healthcare Conference in […]

by

SAN DIEGO, CA–(Marketwired – November 09, 2016) – Kannaway, LLC, the first hemp lifestyle direct selling company to offer cannabidiol (CBD) hemp botanical products, has added a new multi-level marketing expert to its team, Randy Schroeder, who brings with him a 25-year training module to the Company. Topics include “Why Network Marketing” and “Mastering the […]

by

DEVON, Pa., Nov. 09, 2016 — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate at various upcoming investor meetings and conferences. Armando Anido, Chairman and CEO, will present at the Jefferies London Healthcare Conference in London, UK, […]

by

DEVON, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate at various upcoming investor meetings and conferences. Armando Anido, Chairman and CEO, will present at the Jefferies London Healthcare Conference in […]

by

November 9, 2016 (Investorideas.com Newswire) Investorideas.com, a global news source and investor resource issues an updated directory and news alert for Marijuana and Hemp Stocks following the US election and the legalization in new States. Approved: California voters approved recreational marijuana Approved: Massachusetts also voted for recreational marijuana Approved: Nevada approved recreational marijuana Approved: Florida […]

by

DEVON, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced that the Company will participate at various upcoming investor meetings and conferences. Armando Anido, Chairman and CEO, will present at the Jefferies London Healthcare Conference in […]

by

A new clinical trial is now open in Australia for people with Osteoarthritis knee pain. People who have been medically diagnosed as having Osteoarthritis in one OR both knees for at least the past 12 months could be eligible for a clinical trial of a skin gel containing cannabidiol. Participating Clinics include leading hospitals and medical centres in Queensland, […]

by

SAN DIEGO, CA–(Marketwired – November 07, 2016) – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the Company’s Chief Executive Officer Dr. Stuart Titus was a special guest on Radio America Network’s Equity Strategies show on Sunday, Nov. 6. Dr. Titus spoke to Equity Strategies’ […]

by

REDONDO BEACH, CA — (Marketwired) — 11/07/16 — SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article taking a closer look at AXIM Biotechnologies’ (OTCQB: AXIM) cannabinoid-based clinical trials program. AXIM is advancing their patented controlled-release cannabinoid gum in studies covering a number of indications. […]

by

REDONDO BEACH, CA–(Marketwired – Nov 7, 2016) – SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an article taking a closer look at AXIM Biotechnologies’ (OTCQB: AXIM) cannabinoid-based clinical trials program. AXIM is advancing their patented controlled-release cannabinoid gum in studies covering a number of indications. […]

by

Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic cannabinoid treatments, today announced the enrollment of the first patients into the STAR 2 (Synthetic Transdermal Cannabidiol for the Treatment of Epilepsy) clinical trial, an open-label extension trial which allows patients who have completed  the STAR 1 clinical trial […]

by

reader comments 131 Whatever happens November 8, marijuana won. It’s hit an all time high in popularity—60 percent of Americans now support legalization. That handily beats both major-party candidates in favorability. Twenty-five states and Washington, DC have already legalized it for medical use. And come election day, nine states will decide whether to loosen laws […]

by

reader comments 46 Whatever happens November 8, marijuana won. It’s hit an all time high in popularity—60 percent of Americans now support legalization. That handily beats both major-party candidates in favorability. Twenty-five states and Washington, DC have already legalized it for medical use. And come election day, nine states will decide whether to loosen laws […]

by

VANCOUVER, BRITISH COLUMBIA — (Marketwired) — 11/04/16 — Cameo Resources Inc. (TSX VENTURE: CRU)(OTC PINK: SIDNF) (the “Company”) is pleased to announce that the board of directors and the management team have been exploring multiple acquisition opportunities in the medical marijuana and CBD oil industry. The company has been reviewing legislation in those US States […]

by

OTTAWA, ONTARIO–(Marketwired – Nov 2, 2016) – Tetra Bio-Pharma Inc. (“TetraBio” or the “Company“) (CSE:TBP) through its subsidiary, PhytoPain Pharma Inc. (“PPP“), is pleased to announce that it held its Scientific and Clinical Advisory Board (“CAB“) meeting on October 29th. The CAB reviewed the development program of PPP’s inhalation cannabis product PPP001. PPP001 is a […]

by